{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T07:03:35Z","timestamp":1792047815530,"version":"4.4.0"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1116955"],"award-info":[{"award-number":["1116955"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1054618"],"award-info":[{"award-number":["1054618"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023250","name":"Lorenzo and Pamela Galli Charitable Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100023250","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although melanoma is initiated by acquisition of point mutations and limited focal copy number alterations in melanocytes-of-origin, the nature of genetic changes that characterise lethal metastatic disease is poorly understood. Here, we analyze the evolution of human melanoma progressing from early to late disease in 13 patients by sampling their tumours at multiple sites and times. Whole exome and genome sequencing data from 88 tumour samples reveals only limited gain of point mutations generally, with net mutational loss in some metastases. In contrast, melanoma evolution is dominated by whole genome doubling and large-scale aneuploidy, in which widespread loss of heterozygosity sculpts the burden of point mutations, neoantigens and structural variants even in treatment-na\u00efve and primary cutaneous melanomas in some patients. These results imply that dysregulation of genomic integrity is a key driver of selective clonal advantage during melanoma progression.<\/jats:p>","DOI":"10.1038\/s41467-021-21576-8","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T11:03:59Z","timestamp":1614855839000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2960-2967","authenticated-orcid":false,"given":"Ismael A.","family":"Vergara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Mintoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahneen","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lachlan","family":"McIntosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Q.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Colebatch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0951-7116","authenticated-orcid":false,"given":"Daniel L.","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Lai","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2126-1045","authenticated-orcid":false,"given":"Rory","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6046-5139","authenticated-orcid":false,"given":"Jason","family":"Ellul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelin","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9005-3485","authenticated-orcid":false,"given":"Gisela Mir","family":"Arnau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Raleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5084-7662","authenticated-orcid":false,"given":"Athena","family":"Hatzimihalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6159-9913","authenticated-orcid":false,"given":"Pacman","family":"Szeto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Mooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Widmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2940-006X","authenticated-orcid":false,"given":"Phil F.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie","family":"Amann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2279-6906","authenticated-orcid":false,"given":"Reinhard","family":"Dummer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4760-1033","authenticated-orcid":false,"given":"Nicholas","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6750-5244","authenticated-orcid":false,"given":"James","family":"Wilmott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8991-0013","authenticated-orcid":false,"given":"Richard A.","family":"Scolyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bowtell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Alsop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Cordner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Woodford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie","family":"Leditschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8276-0374","authenticated-orcid":false,"given":"Sarah-Jane","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant A.","family":"McArthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1301-405X","authenticated-orcid":false,"given":"Graham J.","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell P.","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1102-8506","authenticated-orcid":false,"given":"Anthony T.","family":"Papenfuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7673-4655","authenticated-orcid":false,"given":"Mark","family":"Shackleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"21576_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/ng1054","volume":"33","author":"PM Pollock","year":"2003","unstructured":"Pollock, P. M. et al. High frequency of BRAF mutations in nevi. Nat. Genet 33, 19\u201320 (2003).","journal-title":"Nat. Genet"},{"key":"21576_CR2","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/01.cmr.0000222600.73179.f3","volume":"16","author":"JN Poynter","year":"2006","unstructured":"Poynter, J. N. et al. BRAF and NRAS mutations in melanoma and melanocytic nevi. Melanoma Res. 16, 267\u2013273 (2006).","journal-title":"Melanoma Res."},{"key":"21576_CR3","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1111\/pcmr.12412","volume":"28","author":"MR Roh","year":"2015","unstructured":"Roh, M. R., Eliades, P., Gupta, S. & Tsao, H. Genetics of melanocytic nevi. Pigment Cell Melanoma Res. 28, 661\u2013672 (2015).","journal-title":"Pigment Cell Melanoma Res."},{"key":"21576_CR4","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nature22071","volume":"545","author":"NK Hayward","year":"2017","unstructured":"Hayward, N. K. et al. Whole-genome landscapes of major melanoma subtypes. Nature 545, 175\u2013180 (2017).","journal-title":"Nature"},{"key":"21576_CR5","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","volume":"161","author":"Cancer Genome Atlas, N.","year":"2015","unstructured":"Cancer Genome Atlas, N. Genomic classification of cutaneous melanoma. Cell 161, 1681\u20131696 (2015).","journal-title":"Cell"},{"key":"21576_CR6","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","volume":"373","author":"AH Shain","year":"2015","unstructured":"Shain, A. H. et al. The genetic evolution of melanoma from precursor lesions. N. Engl. J. Med. 373, 1926\u20131936 (2015).","journal-title":"N. Engl. J. Med."},{"key":"21576_CR7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1126\/science.1230062","volume":"339","author":"S Horn","year":"2013","unstructured":"Horn, S. et al. TERT promoter mutations in familial and sporadic melanoma. Science 339, 959\u2013961 (2013).","journal-title":"Science"},{"key":"21576_CR8","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.1229259","volume":"339","author":"FW Huang","year":"2013","unstructured":"Huang, F. W. et al. Highly recurrent TERT promoter mutations in human melanoma. Science 339, 957\u2013959 (2013).","journal-title":"Science"},{"key":"21576_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/nature11071","volume":"485","author":"MF Berger","year":"2012","unstructured":"Berger, M. F. et al. Melanoma genome sequencing reveals frequent PREX2 mutations. Nature 485, 502\u2013506 (2012).","journal-title":"Nature"},{"key":"21576_CR10","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/ng.2359","volume":"44","author":"M Krauthammer","year":"2012","unstructured":"Krauthammer, M. et al. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat. Genet. 44, 1006\u20131014 (2012).","journal-title":"Nat. Genet."},{"key":"21576_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cell.2012.06.024","volume":"150","author":"E Hodis","year":"2012","unstructured":"Hodis, E. et al. A landscape of driver mutations in melanoma. Cell 150, 251\u2013263 (2012).","journal-title":"Cell"},{"key":"21576_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/pcmr.12560","volume":"30","author":"J Turner","year":"2017","unstructured":"Turner, J. et al. Kinase gene fusions in defined subsets of melanoma. Pigment Cell Melanoma Res. 30, 53\u201362 (2017).","journal-title":"Pigment Cell Melanoma Res."},{"key":"21576_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms5846","volume":"5","author":"N Stransky","year":"2014","unstructured":"Stransky, N., Cerami, E., Schalm, S., Kim, J. L. & Lengauer, C. The landscape of kinase fusions in cancer. Nat. Commun. 5, 4846 (2014).","journal-title":"Nat. Commun."},{"key":"21576_CR14","doi-asserted-by":"publisher","first-page":"4765","DOI":"10.1158\/0008-5472.CAN-15-3476","volume":"76","author":"K Harbst","year":"2016","unstructured":"Harbst, K. et al. Multiregion whole-exome sequencing uncovers the genetic evolution and mutational heterogeneity of early-stage metastatic melanoma. Cancer Res. 76, 4765\u20134774 (2016).","journal-title":"Cancer Res."},{"key":"21576_CR15","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1056\/NEJMoa1113205","volume":"366","author":"M Gerlinger","year":"2012","unstructured":"Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883\u2013892 (2012).","journal-title":"N. Engl. J. Med."},{"key":"21576_CR16","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nature14410","volume":"521","author":"AM Patch","year":"2015","unstructured":"Patch, A. M. et al. Whole-genome characterization of chemoresistant ovarian cancer. Nature 521, 489\u2013494 (2015).","journal-title":"Nature"},{"key":"21576_CR17","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/nature19823","volume":"538","author":"F Notta","year":"2016","unstructured":"Notta, F. et al. A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns. Nature 538, 378\u2013382 (2016).","journal-title":"Nature"},{"key":"21576_CR18","doi-asserted-by":"publisher","first-page":"e1002204","DOI":"10.1371\/journal.pmed.1002204","volume":"13","author":"P Savas","year":"2016","unstructured":"Savas, P. et al. The subclonal architecture of metastatic breast cancer: results from a prospective community-based rapid autopsy program \u201cCASCADE\u201d. PLoS Med. 13, e1002204 (2016).","journal-title":"PLoS Med."},{"key":"21576_CR19","doi-asserted-by":"publisher","first-page":"10995","DOI":"10.1073\/pnas.1508074112","volume":"112","author":"JZ Sanborn","year":"2015","unstructured":"Sanborn, J. Z. et al. Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination. Proc. Natl Acad. Sci. USA 112, 10995\u201311000 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"21576_CR20","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.15252\/emmm.201404914","volume":"7","author":"K Kemper","year":"2015","unstructured":"Kemper, K. et al. Intra- and inter-tumor heterogeneity in a vemurafenib-resistant melanoma patient and derived xenografts. EMBO Mol. Med. 7, 1104\u20131118 (2015).","journal-title":"EMBO Mol. Med."},{"key":"21576_CR21","doi-asserted-by":"publisher","first-page":"77163","DOI":"10.18632\/oncotarget.12848","volume":"7","author":"MI Raaijmakers","year":"2016","unstructured":"Raaijmakers, M. I. et al. Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance. Oncotarget 7, 77163\u201377174 (2016).","journal-title":"Oncotarget"},{"key":"21576_CR22","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1038\/nbt.3674","volume":"34","author":"K Alsop","year":"2016","unstructured":"Alsop, K. et al. A community-based model of rapid autopsy in end-stage cancer patients. Nat. Biotechnol. 34, 1010\u20131014 (2016).","journal-title":"Nat. Biotechnol."},{"key":"21576_CR23","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nature12477","volume":"500","author":"LB Alexandrov","year":"2013","unstructured":"Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415\u2013421 (2013).","journal-title":"Nature"},{"key":"21576_CR24","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/sj.bjc.6602970","volume":"94","author":"B Karakas","year":"2006","unstructured":"Karakas, B., Bachman, K. E. & Park, B. H. Mutation of the PIK3CA oncogene in human cancers. Br. J. Cancer 94, 455\u2013459 (2006).","journal-title":"Br. J. Cancer"},{"key":"21576_CR25","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.ccr.2011.10.030","volume":"20","author":"WE Damsky","year":"2011","unstructured":"Damsky, W. E. et al. beta-catenin signaling controls metastasis in Braf-activated Pten-deficient melanomas. Cancer Cell 20, 741\u2013754 (2011).","journal-title":"Cancer Cell"},{"key":"21576_CR26","doi-asserted-by":"publisher","first-page":"10193","DOI":"10.1073\/pnas.1733909100","volume":"100","author":"O Marin","year":"2003","unstructured":"Marin, O. et al. A noncanonical sequence phosphorylated by casein kinase 1 in beta-catenin may play a role in casein kinase 1 targeting of important signaling proteins. Proc. Natl Acad. Sci. USA 100, 10193\u201310200 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"21576_CR27","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nbt.3391","volume":"34","author":"MT Chang","year":"2016","unstructured":"Chang, M. T. et al. Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. Nat. Biotechnol. 34, 155\u2013163 (2016).","journal-title":"Nat. Biotechnol."},{"key":"21576_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02002-4","volume":"8","author":"IM Berenjeno","year":"2017","unstructured":"Berenjeno, I. M. et al. Oncogenic PIK3CA induces centrosome amplification and tolerance to genome doubling. Nat. Commun. 8, 1773 (2017).","journal-title":"Nat. Commun."},{"key":"21576_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02674-y","volume":"9","author":"M Werner-Klein","year":"2018","unstructured":"Werner-Klein, M. et al. Genetic alterations driving metastatic colony formation are acquired outside of the primary tumour in melanoma. Nat. Commun. 9, 595 (2018).","journal-title":"Nat. Commun."},{"key":"21576_CR30","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1056\/NEJMoa1616288","volume":"376","author":"M Jamal-Hanjani","year":"2017","unstructured":"Jamal-Hanjani, M. et al. Tracking the evolution of non-small-cell lung cancer. N. Engl. J. Med. 376, 2109\u20132121 (2017).","journal-title":"N. Engl. J. Med."},{"key":"21576_CR31","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","volume":"32","author":"M Andreatta","year":"2016","unstructured":"Andreatta, M. & Nielsen, M. Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics 32, 511\u2013517 (2016).","journal-title":"Bioinformatics"},{"key":"21576_CR32","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1110\/ps.0239403","volume":"12","author":"M Nielsen","year":"2003","unstructured":"Nielsen, M. et al. Reliable prediction of T-cell epitopes using neural networks with novel sequence representations. Protein Sci. 12, 1007\u20131017 (2003).","journal-title":"Protein Sci."},{"key":"21576_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nm.3773","volume":"21","author":"C Linnemann","year":"2015","unstructured":"Linnemann, C. et al. High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma. Nat. Med. 21, 81\u201385 (2015).","journal-title":"Nat. Med."},{"key":"21576_CR34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature18945","volume":"536","author":"EM Verdegaal","year":"2016","unstructured":"Verdegaal, E. M. et al. Neoantigen landscape dynamics during human melanoma-T cell interactions. Nature 536, 91\u201395 (2016).","journal-title":"Nature"},{"key":"21576_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.coi.2014.01.004","volume":"27","author":"D Mittal","year":"2014","unstructured":"Mittal, D., Gubin, M. M., Schreiber, R. D. & Smyth, M. J. New insights into cancer immunoediting and its three component phases-elimination, equilibrium and escape. Curr. Opin. Immunol. 27, 16\u201325 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"21576_CR36","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/DAD.0b013e31819f8316","volume":"31","author":"P Pouryazdanparast","year":"2009","unstructured":"Pouryazdanparast, P., Newman, M., Mafee, M., Guitart, J. & Gerami, P. Malignant melanoma with monster cells showing massive cyclin D1 amplification. Am. J. Dermatopathol. 31, 402\u2013403 (2009).","journal-title":"Am. J. Dermatopathol."},{"key":"21576_CR37","doi-asserted-by":"publisher","first-page":"9131","DOI":"10.1093\/nar\/gku590","volume":"42","author":"A L\u2019Abbate","year":"2014","unstructured":"L\u2019Abbate, A. et al. Genomic organization and evolution of double minutes\/homogeneously staining regions with MYC amplification in human cancer. Nucleic Acids Res. 42, 9131\u20139145 (2014).","journal-title":"Nucleic Acids Res."},{"key":"21576_CR38","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.celrep.2015.06.065","volume":"12","author":"AM Laughney","year":"2015","unstructured":"Laughney, A. M., Elizalde, S., Genovese, G. & Bakhoum, S. F. Dynamics of tumor heterogeneity derived from clonal karyotypic evolution. Cell Rep. 12, 809\u2013820 (2015).","journal-title":"Cell Rep."},{"key":"21576_CR39","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/2159-8290.CD-13-0285","volume":"4","author":"SM Dewhurst","year":"2014","unstructured":"Dewhurst, S. M. et al. Tolerance of whole-genome doubling propagates chromosomal instability and accelerates cancer genome evolution. Cancer Discov. 4, 175\u2013185 (2014).","journal-title":"Cancer Discov."},{"key":"21576_CR40","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1126\/science.1235122","volume":"339","author":"B Vogelstein","year":"2013","unstructured":"Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546\u20131558 (2013).","journal-title":"Science"},{"key":"21576_CR41","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1038\/nrc924","volume":"2","author":"EA Nigg","year":"2002","unstructured":"Nigg, E. A. Centrosome aberrations: cause or consequence of cancer progression? Nat. Rev. Cancer 2, 815\u2013825 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"21576_CR42","doi-asserted-by":"publisher","first-page":"R285","DOI":"10.1016\/j.cub.2010.01.034","volume":"20","author":"SL Thompson","year":"2010","unstructured":"Thompson, S. L., Bakhoum, S. F. & Compton, D. A. Mechanisms of chromosomal instability. Curr. Biol. 20, R285\u2013R295 (2010).","journal-title":"Curr. Biol."},{"key":"21576_CR43","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/ncb2958","volume":"16","author":"H Maiato","year":"2014","unstructured":"Maiato, H. & Logarinho, E. Mitotic spindle multipolarity without centrosome amplification. Nat. Cell Biol. 16, 386\u2013394 (2014).","journal-title":"Nat. Cell Biol."},{"key":"21576_CR44","doi-asserted-by":"publisher","first-page":"10320","DOI":"10.18632\/oncotarget.3583","volume":"6","author":"D Valente","year":"2015","unstructured":"Valente, D. et al. HIPK2 deficiency causes chromosomal instability by cytokinesis failure and increases tumorigenicity. Oncotarget 6, 10320\u201310334 (2015).","journal-title":"Oncotarget"},{"key":"21576_CR45","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.molonc.2011.07.007","volume":"5","author":"Y Aylon","year":"2011","unstructured":"Aylon, Y. & Oren, M. p53: guardian of ploidy. Mol. Oncol. 5, 315\u2013323 (2011).","journal-title":"Mol. Oncol."},{"key":"21576_CR46","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/sj.onc.1202410","volume":"18","author":"XY Yin","year":"1999","unstructured":"Yin, X. Y., Grove, L., Datta, N. S., Long, M. W. & Prochownik, E. V. C-myc overexpression and p53 loss cooperate to promote genomic instability. Oncogene 18, 1177\u20131184 (1999).","journal-title":"Oncogene"},{"key":"21576_CR47","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1091\/mbc.e05-08-0810","volume":"17","author":"X Yan","year":"2006","unstructured":"Yan, X., Habedanck, R. & Nigg, E. A. A complex of two centrosomal proteins, CAP350 and FOP, cooperates with EB1 in microtubule anchoring. Mol. Biol. Cell 17, 634\u2013644 (2006).","journal-title":"Mol. Biol. Cell"},{"key":"21576_CR48","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1083\/jcb.200705126","volume":"180","author":"LM Pirzio","year":"2008","unstructured":"Pirzio, L. M., Pichierri, P., Bignami, M. & Franchitto, A. Werner syndrome helicase activity is essential in maintaining fragile site stability. J. Cell Biol. 180, 305\u2013314 (2008).","journal-title":"J. Cell Biol."},{"key":"21576_CR49","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/375506a0","volume":"375","author":"J Koh","year":"1995","unstructured":"Koh, J., Enders, G. H., Dynlacht, B. D. & Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature 375, 506\u2013510 (1995).","journal-title":"Nature"},{"key":"21576_CR50","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1128\/MCB.15.1.552","volume":"15","author":"M Hattori","year":"1995","unstructured":"Hattori, M. et al. Molecular cloning of a novel mitogen-inducible nuclear protein with a Ran GTPase-activating domain that affects cell cycle progression. Mol. Cell Biol. 15, 552\u2013560 (1995).","journal-title":"Mol. Cell Biol."},{"key":"21576_CR51","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1038\/sj.onc.1207593","volume":"23","author":"B Delaval","year":"2004","unstructured":"Delaval, B. et al. Aurora B -TACC1 protein complex in cytokinesis. Oncogene 23, 4516\u20134522 (2004).","journal-title":"Oncogene"},{"key":"21576_CR52","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1242\/jcs.069963","volume":"123","author":"M Archinti","year":"2010","unstructured":"Archinti, M., Lacasa, C., Teixido-Travesa, N. & Luders, J. SPICE-a previously uncharacterized protein required for centriole duplication and mitotic chromosome congression. J. Cell Sci. 123, 3039\u20133046 (2010).","journal-title":"J. Cell Sci."},{"key":"21576_CR53","doi-asserted-by":"publisher","first-page":"27670","DOI":"10.1074\/jbc.M112.378968","volume":"287","author":"M Ikeda","year":"2012","unstructured":"Ikeda, M., Chiba, S., Ohashi, K. & Mizuno, K. Furry protein promotes aurora A-mediated Polo-like kinase 1 activation. J. Biol. Chem. 287, 27670\u201327681 (2012).","journal-title":"J. Biol. Chem."},{"key":"21576_CR54","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/1098-2264(200008)28:4<359::AID-GCC1>3.0.CO;2-N","volume":"28","author":"II Wistuba","year":"2000","unstructured":"Wistuba, I. I. et al. Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome. Genes Chromosomes Cancer 28, 359\u2013369 (2000).","journal-title":"Genes Chromosomes Cancer"},{"key":"21576_CR55","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1101\/gr.220707.117","volume":"27","author":"J Kuipers","year":"2017","unstructured":"Kuipers, J., Jahn, K., Raphael, B. J. & Beerenwinkel, N. Single-cell sequencing data reveal widespread recurrence and loss of mutational hits in the life histories of tumors. Genome Res. 27, 1885\u20131894 (2017).","journal-title":"Genome Res."},{"key":"21576_CR56","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1158\/2159-8290.CD-13-0617","volume":"4","author":"EM Van Allen","year":"2014","unstructured":"Van Allen, E. M. et al. The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma. Cancer Discov. 4, 94\u2013109 (2014).","journal-title":"Cancer Discov."},{"key":"21576_CR57","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2159-8290.CD-13-0642","volume":"4","author":"H Shi","year":"2014","unstructured":"Shi, H. et al. Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy. Cancer Discov. 4, 80\u201393 (2014).","journal-title":"Cancer Discov."},{"key":"21576_CR58","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","volume":"168","author":"P Sharma","year":"2017","unstructured":"Sharma, P., Hu-Lieskovan, S., Wargo, J. A. & Ribas, A. Primary, adaptive, and acquired resistance to cancer immunotherapy. Cell 168, 707\u2013723 (2017).","journal-title":"Cell"},{"key":"21576_CR59","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1242\/jcs.039537","volume":"121","author":"Z Storchova","year":"2008","unstructured":"Storchova, Z. & Kuffer, C. The consequences of tetraploidy and aneuploidy. J. Cell Sci. 121, 3859\u20133866 (2008).","journal-title":"J. Cell Sci."},{"key":"21576_CR60","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/nbt.2203","volume":"30","author":"SL Carter","year":"2012","unstructured":"Carter, S. L. et al. Absolute quantification of somatic DNA alterations in human cancer. Nat. Biotechnol. 30, 413\u2013421 (2012).","journal-title":"Nat. Biotechnol."},{"key":"21576_CR61","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1038\/ng.2760","volume":"45","author":"TI Zack","year":"2013","unstructured":"Zack, T. I. et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet 45, 1134\u20131140 (2013).","journal-title":"Nat. Genet"},{"key":"21576_CR62","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/00000658-198804000-00014","volume":"207","author":"SM Kheir","year":"1988","unstructured":"Kheir, S. M. et al. Prognostic significance of DNA aneuploidy in stage I cutaneous melanoma. Ann. Surg. 207, 455\u2013461 (1988).","journal-title":"Ann. Surg."},{"key":"21576_CR63","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/j.1600-0560.1995.tb00746.x","volume":"22","author":"VB Reddy","year":"1995","unstructured":"Reddy, V. B., Gattuso, P., Aranha, G. & Carson, H. J. Cell proliferation markers in predicting metastases in malignant melanoma. J. Cutan. Pathol. 22, 248\u2013251 (1995).","journal-title":"J. Cutan. Pathol."},{"key":"21576_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/srep03494","volume":"3","author":"SQ Wong","year":"2013","unstructured":"Wong, S. Q. et al. Targeted-capture massively-parallel sequencing enables robust detection of clinically informative mutations from formalin-fixed tumours. Sci. Rep. 3, 3494 (2013).","journal-title":"Sci. Rep."},{"key":"21576_CR65","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.clinbiochem.2014.12.007","volume":"48","author":"AL Reid","year":"2015","unstructured":"Reid, A. L., Freeman, J. B., Millward, M., Ziman, M. & Gray, E. S. Detection of BRAF-V600E and V600K in melanoma circulating tumour cells by droplet digital PCR. Clin. Biochem 48, 999\u20131002 (2015).","journal-title":"Clin. Biochem"},{"key":"21576_CR66","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/nar\/gkv135","volume":"43,","author":"M Josephidou","year":"2015","unstructured":"Josephidou, M., Lynch, A. G. & Tavare, S. multiSNV: a probabilistic approach for improving detection of somatic point mutations from multiple related tumour samples. Nucleic Acids Res. 43,, e61 (2015).","journal-title":"Nucleic Acids Res."},{"key":"21576_CR67","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt, D. C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568\u2013576 (2012).","journal-title":"Genome Res."},{"key":"21576_CR68","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nbt.2514","volume":"31","author":"K Cibulskis","year":"2013","unstructured":"Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213\u2013219 (2013).","journal-title":"Nat. Biotechnol."},{"key":"21576_CR69","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna, A. et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 20, 1297\u20131303 (2010).","journal-title":"Genome Res."},{"key":"21576_CR70","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-016-0893-4","volume":"17","author":"R Rosenthal","year":"2016","unstructured":"Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 17, 31 (2016).","journal-title":"Genome Biol."},{"key":"21576_CR71","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"21576_CR72","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1093\/annonc\/mdu479","volume":"26","author":"F Favero","year":"2015","unstructured":"Favero, F. et al. Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data. Ann. Oncol. 26, 64\u201370 (2015).","journal-title":"Ann. Oncol."},{"key":"21576_CR73","doi-asserted-by":"publisher","unstructured":"Cameron, D. L. et al. GRIDSS: sensitive and specific genomic rearrangement detection using positional de Bruijn graph assembly. Genome Res. https:\/\/doi.org\/10.1101\/gr.222109.117 (2017).","DOI":"10.1101\/gr.222109.117"},{"key":"21576_CR74","doi-asserted-by":"publisher","first-page":"e1003535","DOI":"10.1371\/journal.pcbi.1003535","volume":"10","author":"RF Schwarz","year":"2014","unstructured":"Schwarz, R. F. et al. Phylogenetic quantification of intra-tumour heterogeneity. PLoS Comput Biol. 10, e1003535 (2014).","journal-title":"PLoS Comput Biol."},{"key":"21576_CR75","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1096-0031.2008.00217.x","volume":"24","author":"PA Goloboff","year":"2008","unstructured":"Goloboff, P. A., Farris, J. S. & Nixon, K. C. TNT, a free program for phylogenetic analysis. Cladistics 24, 774\u2013786 (2008).","journal-title":"Cladistics"},{"key":"21576_CR76","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike, H. A new look at the statistical model identification. IEEE Trans. Autom. Control 19, 716\u2013723 (1974).","journal-title":"IEEE Trans. Autom. Control"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21576-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21576-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21576-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T11:15:53Z","timestamp":1669979753000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-21576-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["21576"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-21576-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"assertion":[{"value":"14 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.D. and M.S. have intermittent, project focused consulting and\/or advisory relationships with Novartis, Merck Sharp & Dhome (MSD), Bristol-Myers Squibb (BMS), Merck-Serono, Roche, Amgen, Takeda, Pierre Fabre, and\/or Sun Pharma that are unrelated to the submitted work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1434"}}